This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Svetlana Sienkiewicz: Innovator in Pharmaceutical Formulations
Introduction
Svetlana Sienkiewicz is a notable inventor based in New Milford, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of extended release formulations. Her work has the potential to improve patient outcomes through innovative drug delivery systems.
Latest Patents
Sienkiewicz holds a patent for an extended release formulation of nevirapine. This invention relates to a pharmaceutical composition that provides a sustained release of nevirapine, which is crucial for effective treatment regimens.
Career Highlights
Throughout her career, Sienkiewicz has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. Her experience in these organizations has allowed her to develop her expertise in drug formulation and delivery.
Collaborations
Sienkiewicz has collaborated with esteemed colleagues such as Michael L. Cappola and Glenn Charles Snow. These partnerships have contributed to her innovative work and have fostered advancements in pharmaceutical research.
Conclusion
Svetlana Sienkiewicz is a pioneering inventor whose work in extended release formulations has the potential to enhance therapeutic efficacy. Her contributions to the pharmaceutical industry reflect her dedication to improving healthcare through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile